BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries
Go back to BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries| Bank of Commerce (NASDAQ: ONC) | Delayed: 365.67 +14.83 (4.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $350.84 | 52 Week High | $0.35 | |||
| Open | $360.42 | 52 Week Low | $0.35 | |||
| Day High | $367.00 | P/E | N/A | |||
| Day Low | $358.24 | EPS | $0.00 | |||
| Volume | 488,976 | |||||
